임상 의사결정 지원 소프트웨어 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the clinical decision support software market size is projected to expand from USD 5.80 billion in 2025 and USD 6.53 billion in 2026 to USD 11.80 billion by 2031, registering a CAGR of 12.56% between 2026 to 2031.

This report is Segmented by Product Architecture (Integrated CDSS, Standalone CDSS), Component (Software, Services), Delivery Mode (On-Premise, Cloud-Based, Hybrid), Clinical Function (Diagnostic Decision Support, and More), Application (Drug Allergy Alerts, and More), End User (Hospitals, Aand More), and Geography (North America, Europe, Asia-Pacific, and More). Forecasts are in Value (USD).

Global Clinical Decision Support Software Market Trends and Insights

EHR and Clinical Workflow Digitization

Electronic health record adoption in the United States and Western Europe has created a replacement cycle for older decision support modules. Health systems are adding AI-enabled tools as earlier modules no longer meet current workflow needs. A 2025 meta-analysis found a 15% reduction in medication errors with electronic decision support, with a relative risk of 0.85 and a 95% confidence interval of 0.70-0.94. Oracle Health made its Clinical AI Agent generally available in March 2026 for U.S. inpatient and emergency department settings. Its earlier deployment at AtlantiCare reduced documentation time by 41%, and the company reported more than 200,000 cumulative hours saved for U.S. providers. The clinical decision support software market favors products that deliver measurable value within existing clinical workflows.

Government Certification and Interoperability Mandates

Regulation is shaping product design and compliance activity in the clinical decision support software market. The Office of the National Coordinator for Health Information Technology published the HTI-4 Final Rule in July 2025, adding an API-based clinical decision support criterion for standardized delivery within electronic health record workflows. The agency estimated that related efficiencies could save USD 19 billion in labor costs over 10 years. The HTI-5 Proposed Rule, published December 29, 2025, proposed AI-enabled interoperability through FHIR application programming interfaces. This direction could favor modular products over closed deployments, while certification and CMS requirements accelerate hospital procurement cycles. European Health Data Space requirements and Indian medical device rules are extending the same demand for interoperable systems.

Alert Fatigue and Workflow Disruption

Alert fatigue weakens the clinical and financial case for decision support investment. A 2025 study found that only 19.6% of alerts with appropriate clinical content were patient-relevant in a locally configured medication system. A quasi-experimental study found that high-severity interruptive alerts reduced potential drug-drug interactions but did not reduce clinically relevant interactions or patient harm. Hospitals assessed alert specificity, override reasons, and post-implementation outcomes more closely, extending implementation and procurement timelines in the clinical decision support software market.

Other drivers and restraints analyzed in the detailed report include:

1. Rising Medication Safety and Quality-Reporting Requirements
2. AI-Assisted Alert Optimization
3. High Customization and Maintenance Cost

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Integrated CDSS accounted for 58.23% of the clinical decision support software market share in 2025. This position reflected electronic health record contract economics, which made standalone alternatives difficult to justify for hospitals committed to Epic or Oracle Health environments. Integration reduced context switching and kept recommendations within clinicians' routine workflows. A 2026 systematic review found that Epic's decision support tools managed records for more than 325 million patients globally, giving integrated products a substantial data and workflow advantage.

Standalone CDSS is forecast to grow at a 15.25% CAGR from 2026 to 2031. It is gaining traction in specialties where bundled electronic health record functions can be less capable, including oncology order management, sepsis prediction, and imaging-linked diagnostic support. Elsevier acquired Wellsheet in June 2026 to combine patient data aggregation with ClinicalKey AI evidence content. Wellsheet was deployed across 139 U.S. hospital sites, while ClinicalKey AI content was used in more than 300 hospitals globally. CDS Hooks is narrowing the line between integrated and standalone offerings by allowing external services to display recommendations inside electronic health record interfaces.

Services held 43.64% of revenue in 2025. Implementation, customization, and managed-content work remained necessary for large hospital deployments with complex electronic health record environments. Multi-year contracts supported this share of the clinical decision support software market. Services also helped providers tailor alerts, workflows, and content to local clinical practice, especially in systems with older infrastructure or varied departments.

Software is forecast to expand at a 17.67% CAGR from 2026 to 2031. Cloud-native designs can automate updates and reduce dependence on professional services for version management. Wolters Kluwer reported that UpToDate Expert AI reached more than 3 million clinician users after its fourth-quarter 2025 launch. Continuously updated evidence products can support subscription pricing while lowering service intensity, pressuring suppliers that rely heavily on consulting revenue to strengthen AI-enabled subscriptions.

Complete Report Scope:

• By Product Architecture
  • Integrated CDSS
  • Standalone CDSS
• By Component
  • Software
  • Services
• By Delivery Mode
  • On-Premise
  • Cloud-Based
  • Hybrid
• By Clinical Function
  • Diagnostic Decision Support
  • Therapeutic Decision Support
  • Medication Management
  • Care Pathway and Guideline Management
  • Risk Prediction and Early Warning
  • Clinical Documentation and Quality Improvement
• By Application
  • Drug Allergy Alerts
  • Drug-Drug Interaction Alerts
  • Dosing and Renal Adjustment
  • Medical Diagnosis
  • Clinical Guidelines and Order Sets
  • Oncology Decision Support
  • Cardiology Decision Support
  • Sepsis and Deterioration Prediction
  • Population Health and Preventive Care
• By End User
  • Hospitals and Health Systems
  • Ambulatory Care Centers
  • Pharmacies and Pharmacy Benefit Managers
  • Specialty Clinics
  • Long-Term Care and Post-Acute Care Providers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 39.67% of clinical decision support software market revenue in 2025. The region benefited from high electronic health record adoption, federal certification systems, and value-based care incentives. The HTI-4 Final Rule introduced an API-based clinical decision support criterion in July 2025, and ONC estimated USD 19 billion in cumulative labor savings over 10 years from related efficiencies. Canada advanced its national health data infrastructure through Canada Health Infoway, while Mexico's IMSS-Bienestar digitalization program began supporting adoption pathways in public hospitals.

Europe followed North America, supported by digital investment in Germany, the United Kingdom, France, and the Nordic countries. The European Health Data Space increased the need for cross-border data exchange standards. Wolters Kluwer renewed UpToDate Enterprise Edition for Norway's nationwide health system in July 2026, covering more than 50 public hospitals and 11,000 beds. These developments increased demand for interoperable products in the clinical decision support software market.

Asia-Pacific is forecast to grow at a 15.56% CAGR from 2026 to 2031. China's healthcare digitalization and AI infrastructure investment support adoption in tier-1 and tier-2 cities. India had more than 1 billion health records linked to ABHA accounts as of May 2026. Japan, South Korea, Australia, and New Zealand are also increasing health IT capacity. Wolters Kluwer launched AI-enhanced UpToDate Enterprise Edition for Asia-Pacific in September 2025, while the Middle East, Africa, and South America remain earlier-stage opportunities.

1. Athenahealth
2. Clinical Architecture
3. EBSCO Information Services, Inc.
4. Elsevier B.V.
5. Epic Systems
6. EvidenceCare, Inc.
7. First Databank, Inc.
8. GE HealthCare Technologies Inc.
9. Intersystems
10. Isabel Healthcare, Inc.
11. Koninklijke Philips
12. Medical Information Technology
13. Merative, Inc.
14. NextGen Healthcare
15. Optum
16. Oracle
17. Siemens Healthineers
18. Veradigm Inc.
19. VisualDx, Inc.
20. Zynx Health, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 EHR and Clinical Workflow Digitization
  • 4.2.2 Government Certification and Interoperability Mandates
  • 4.2.3 Rising Medication Safety and Quality-Reporting Requirements
  • 4.2.4 Expansion of Evidence-Based and Patient-Specific Care
  • 4.2.5 AI-Assisted Alert Optimization
  • 4.2.6 Shareable Standards-Based CDS Content
• 4.3 Market Restraints
  • 4.3.1 Alert Fatigue and Workflow Disruption
  • 4.3.2 High Customization and Maintenance Cost
  • 4.3.3 Weak Patient-Outcome and ROI Evidence
  • 4.3.4 Limited External Validation and Algorithm Trust
• 4.4 Value/Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry
  • 4.7.6 Analysis

5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)

• 5.1 By Product Architecture
  • 5.1.1 Integrated CDSS
  • 5.1.2 Standalone CDSS
• 5.2 By Component
  • 5.2.1 Software
  • 5.2.2 Services
• 5.3 By Delivery Mode
  • 5.3.1 On-Premise
  • 5.3.2 Cloud-Based
  • 5.3.3 Hybrid
• 5.4 By Clinical Function
  • 5.4.1 Diagnostic Decision Support
  • 5.4.2 Therapeutic Decision Support
  • 5.4.3 Medication Management
  • 5.4.4 Care Pathway and Guideline Management
  • 5.4.5 Risk Prediction and Early Warning
  • 5.4.6 Clinical Documentation and Quality Improvement
• 5.5 By Application
  • 5.5.1 Drug Allergy Alerts
  • 5.5.2 Drug-Drug Interaction Alerts
  • 5.5.3 Dosing and Renal Adjustment
  • 5.5.4 Medical Diagnosis
  • 5.5.5 Clinical Guidelines and Order Sets
  • 5.5.6 Oncology Decision Support
  • 5.5.7 Cardiology Decision Support
  • 5.5.8 Sepsis and Deterioration Prediction
  • 5.5.9 Population Health and Preventive Care
• 5.6 By End User
  • 5.6.1 Hospitals and Health Systems
  • 5.6.2 Ambulatory Care Centers
  • 5.6.3 Pharmacies and Pharmacy Benefit Managers
  • 5.6.4 Specialty Clinics
  • 5.6.5 Long-Term Care and Post-Acute Care Providers
  • 5.6.6 Others
• 5.7 By Geography
  • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
  • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
  • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 India
    • 5.7.3.3 Japan
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
  • 5.7.4 Middle East and Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East and Africa
  • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 athenahealth, Inc.
  • 6.3.2 Clinical Architecture, LLC
  • 6.3.3 EBSCO Information Services, Inc.
  • 6.3.4 Elsevier B.V.
  • 6.3.5 Epic Systems Corporation
  • 6.3.6 EvidenceCare, Inc.
  • 6.3.7 First Databank, Inc.
  • 6.3.8 GE HealthCare Technologies Inc.
  • 6.3.9 InterSystems Corporation
  • 6.3.10 Isabel Healthcare, Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Medical Information Technology, Inc.
  • 6.3.13 Merative, Inc.
  • 6.3.14 NextGen Healthcare, Inc.
  • 6.3.15 Optum, Inc.
  • 6.3.16 Oracle Corporation
  • 6.3.17 Siemens Healthineers AG
  • 6.3.18 Veradigm Inc.
  • 6.3.19 VisualDx, Inc.
  • 6.3.20 Zynx Health, Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment